Advanced Haemodynamic Monitoring — PA Catheter, PiCCO & Pulse Contour

Overview & definition

Advanced haemodynamic monitoring goes beyond the basic arterial line and CVP to measure the cardiac output (CO) and related variables continuously or intermittently. Three tiers exist: the pulmonary artery catheter (PAC) (the most invasive, the gold standard), the transpulmonary thermodilution (PiCCO) (less invasive, calibrated), and the uncalibrated pulse contour analysis (FloTrac/Vigileo) (least invasive, less accurate). Each provides different measurements; the choice depends on the clinical question.[1][1]

The guiding principle, restated by every recent consensus, is that monitoring should be matched to the clinical question, not deployed by reflex.[7][10] Escalate from the non-invasive to the invasive only when the cheaper, safer tool cannot answer the question, and when the answer will change management — "do not monitor what you cannot interpret". Every invasive line accumulates complications (infection, thrombosis, ischaemia, rupture), so each device must earn its place at the bedside.[7]

Matching the monitor to the question

Haemodynamic monitoring is not a hierarchy of "better" devices — it is a set of tools that each answer a different question. The art is to define the question first, then choose the least invasive monitor that answers it.[7][10]

The pulmonary artery catheter (PAC / Swan-Ganz)

The most invasive device. A balloon-tipped, flow-directed catheter (7–9 Fr, 110 cm, with a 1.5 mL balloon) is inserted via a central vein (right internal jugular or subclavian) and floated through the right atrium, the RV, and the pulmonary artery, to wedge in a pulmonary arterial branch. The standard PAC has a distal lumen (PA pressure / wedge), a proximal lumen in the RA (CVP, injectate port for thermodilution), a balloon inflation port, a thermistor 3–4 cm from the tip (for thermodilution and continuous SvO2 if oximetric), and — on some — a venous infusion port and a pacing wire.[1][1]

The pressure-tracing "roadmap" — a classic viva

The catheter is floated while watching the pressure trace (and ECG) change as it passes each chamber. Recognising each trace is exam-critical:[1]

The diastolic "step-up" from RV to PA is the key sign that the catheter has crossed the pulmonary valve. The wedge is confirmed by the abrupt fall to a venous-type trace on balloon inflation, and by the wedge pressure being lower than the PA diastolic. Inflate slowly and stop the moment the wedge trace appears — over-wedging risks PA rupture.[1]

What the PAC measures

Measurements:[1]

• Right atrial pressure (the CVP) — from the proximal port.
• Right ventricular pressure (briefly, during transit).
• Pulmonary artery pressure (the PA systolic/diastolic/mean — for pulmonary hypertension; PA diastolic approximates the wedge in the absence of lung disease).
• Pulmonary artery wedge pressure (PAWP / PCWP) — an occlusion pressure reflecting the left atrial pressure (the LV filling pressure), measured by inflating the balloon to occlude a branch PA; the static column transmits LA pressure back to the catheter tip.
• Mixed venous oxygen saturation (SvO2) — from the PA; reflects the balance of O2 delivery and consumption (normal about 70–75 per cent; low in low-output shock or high extraction; high in sepsis with impaired extraction).
• Cardiac output by thermodilution (a cold saline bolus into the RA; the temperature change measured by a PA thermistor — the Stewart-Hamilton method).
• SVR and PVR (calculated).[1]

Normal PAC values and derived parameters

The derived equations are high-yield for the exam:

• SVR = (MAP − CVP) ÷ CO × 80 (in dyn·s·cm⁻⁵)
• PVR = (mPAP − PCWP) ÷ CO × 80
• CO = HR × SV (SV from thermodilution) [1]

Interpreting the wedge pressure (PCWP) — the pitfalls

The wedge pressure is not a perfect surrogate for LV preload. It assumes an open column from the catheter tip to the LA, which can be violated in several classic conditions. The wedge overestimates LV filling pressure in: mitral stenosis (pressure gradient across the valve), left atrial myxoma, positive pressure ventilation with high PEEP (intrathoracic pressure transmitted), chronic pulmonary veno-occlusive disease, and tachycardia (shortened diastole — the "c" wave interrupts the trace). The wedge underestimates LV preload when the wedge is taken in West zone III lung is not achieved (zones I and II have alveolar pressure exceeding venous pressure, so the column is interrupted). Always read the wedge at end-expiration (to minimise intrathoracic pressure artefact) and end-diastole (just before the R wave).[1][1]

Interpreting the SvO2

The mixed venous oxygen saturation (SvO2, sampled from the PA — true mixed venous, distinct from ScvO2 sampled from the SVC) reflects the balance of oxygen delivery (DO2) and consumption (VO2) via the Fick principle: SvO2 ≈ 1 − VO2 / DO2.[1]

A falling SvO2 is an early warning of inadequate resuscitation — it precedes the fall in blood pressure and lactate rise. The ScvO2 (from a central line) is a reasonable surrogate but diverges from SvO2 in shock — the splanchnic bed desaturates disproportionately, so ScvO2 may be misleadingly higher than the true mixed value.[1]

Indications — the justified, current use

After the negative trials, the PAC is reserved for the complex haemodynamic problem where the question cannot be answered by echo or less-invasive devices:[7][1]

• Pulmonary hypertension and RV failure — diagnosis/characterisation (pre-capillary vs post-capillary from the wedge; calculate PVR), and acute decompensation (pulmonary hypertensive crisis). Includes connective-tissue-disease-associated PAH (e.g. systemic sclerosis), where a decompensated pressure-loaded RV needs the PAC to titrate pulmonary vasodilators and inotropes.
• Complex or mixed shock — when the shock type is unclear despite echo and PiCCO, and where the answer will change management (e.g. differentiating septic cardiomyopathy from primary cardiogenic shock; assessing RV infarct).
• Cardiogenic shock on mechanical circulatory support — titration of IABP, Impella, or VA-ECMO against PA pressure, wedge, CO and PVR.
• High-risk cardiac surgery / transplant — perioperative management of severe LV/RV dysfunction, post-cardiac-transplant RV failure.
• Differentiating hydrostatic pulmonary oedema from ARDS — when PiCCO (EVLW/PVPI) is not available or definitive pressure data are needed. [1]

Why PAC use has declined — the evidence

The controversy and the current role.[1] The PAC was once ubiquitous, but the Connors study (JAMA 1996, suggesting increased 30-day mortality with PAC use, OR 1.24) and a run of negative RCTs reduced its routine use:[2]

• Connors (JAMA 1996) — observational study of 5,735 ICU patients suggesting PAC use in the first 24 h was associated with higher 30-day mortality (OR 1.24), longer stay and higher cost.[2]
• PAC-Man (Lancet 2005) — UK RCT, ~1,000 general ICU patients; no difference in hospital mortality; PAC data changed management but did not improve outcome.[4]
• ESCAPE (JAMA 2005) — RCT, 433 patients with severe decompensated heart failure; no improvement in days alive/out of hospital, and more adverse events (21.9% vs 11.5%).[3]
• FACTT (NEJM 2006) — RCT, 1,000 patients with acute lung injury; PAC vs CVC to guide therapy. 60-day mortality no different (27.4% PAC vs 26.3% CVC); more catheter complications with PAC.[5]

Bottom line: the PAC is not dead — it is redeployed. It remains the gold standard when you genuinely need PA pressure, wedge pressure, true mixed SvO2, or to characterise complex pulmonary hypertension, RV failure, or cardiogenic shock on MCS. It is not a monitoring device for the general ICU patient.[1]

Complications

Complications — arrhythmias (the catheter traversing the RV — VT in ~1.5%, usually transient), bundle-branch block (transient RBBB in up to 50% — dangerous with pre-existing LBBB → complete heart block), pulmonary artery rupture (rare but fatal — the catastrophic haemoptysis; risk in anticoagulated, older, female, hypertensive patients), pulmonary infarction (from over-wedging or distal migration), infection, thrombosis, and knotting (especially with redundant RVs in pulmonary HTN / TR).[1][1]

[1]

Transpulmonary thermodilution (PiCCO)

A less invasive alternative. Uses a central venous catheter (for the cold injectate) and a femoral arterial line with a thermistor. A cold bolus (15–20 mL ice-cold saline <8 °C) is injected into the CVC; it traverses the right heart, the lungs, the left heart, and is detected at the femoral artery — the longer transit yields a more stable thermodilution curve than single-pass PAC thermodilution.[1][10]

What PiCCO measures

Measurements:[1]

• Cardiac output by transpulmonary thermodilution (the cold bolus passes through the right heart, the lungs, the left heart, and is detected at the femoral artery — more stable than single-pass PAC thermodilution). Average of three injections spaced through the respiratory cycle.
• Global end-diastolic volume (GEDI / GEDV) and intrathoracic blood volume index (ITBI / ITBV) — volume-based preload markers (better than pressure-based CVP/PAWP for predicting preload and fluid responsiveness). GEDV ≈ the combined end-diastolic volumes of all four chambers; ITBV = GEDV + pulmonary blood volume.
• Extravascular lung water (EVLW) — a marker of pulmonary oedema (the amount of water outside the vasculature in the lungs), indexed to predicted body weight (EVLWI). A high EVLW predicts mortality and guides fluid management — the conservative fluid strategy in ARDS targets a low EVLW.
• Pulmonary vascular permeability index (PVPI) — the ratio of EVLW to pulmonary blood volume (EVLW / PBV); separates hydrostatic oedema (PVPI ~1–2) from permeability oedema / ARDS (PVPI >3).
• Cardiac function index (CFI) and global ejection fraction (GEF) — contractility markers.
• Calibrated pulse contour analysis — a thermodilution measurement calibrates an arterial waveform algorithm that provides a continuous CO, continuous SVV (stroke volume variation — for fluid responsiveness), continuous PPV, and continuous SVR. Recalibrate every 8–12 hours or after a major haemodynamic change.[1]

PiCCO normal values

Why GEDV and EVLW matter

GEDV is a more reliable preload indicator than CVP or PAWP because it measures a volume rather than a distending pressure, and is less confounded by compliance and intrathoracic pressure.[10] EVLW is the standout parameter: it is a direct measure of lung water that predicts mortality in ARDS and septic shock (Sakka 2002 — each step up in EVLW category raises mortality; EVLW >14 mL/kg carries ~65% mortality vs ~33% at normal), guides the fluid strategy (aim for a low or falling EVLW — the conservative-fluid philosophy), and is more sensitive than the CXR or the wedge pressure for detecting pulmonary oedema.[8] The PVPI helps separate hydrostatic from permeability oedema — useful when the CXR is white-out and you need to decide between diuresis and lung-protective ventilation.[1]

Limitations and practical points

• Requires a femoral arterial line (radial thermodilution is less accurate for GEDV/EVLW — under-reads EVLW by ~1 mL/kg).
• Recalibrate every 8–12 h, and after major haemodynamic change (change of vasopressor dose, arrhythmia, position change, post-fluid bolus).
• Intra-cardiac shunt, severe aortic regurgitation, and an IABP distort the thermodilution curve.
• EVLW is underestimated in lung regions with occluded vessels (large pulmonary embolism, pneumonectomy) — because the thermal indicator does not pass through non-perfused lung. [1]

Fluid responsiveness — SVV, PPV and the dynamic tests

PiCCO (and FloTrac) provide SVV and PPV for fluid responsiveness, derived from the arterial waveform under positive-pressure ventilation. The principle: positive-pressure inspiration reduces venous return → stroke volume drops in a preload-dependent (fluid-responsive) patient; the magnitude of the cyclic SV variation predicts responsiveness.[7][10]

SVV/PPV predict responsiveness ONLY if ALL conditions are met:

• Fully controlled mechanical ventilation (no spontaneous breaths)
• Regular cardiac rhythm (NOT atrial fibrillation or frequent ectopics)
• Tidal volume >8 mL/kg (low-tidal-volume ARDS ventilation abolishes the effect)
• Closed chest, compliant chest wall (no open chest, no large air leak)
• No significant right heart failure (RV failure generates its own variation)
• No severe vasopressor-driven vasoconstriction distorting the pulse contour [1]

Threshold: SVV or PPV >12–13% predicts fluid responsiveness (≥10–15% rise in CO/SV to a bolus). When the conditions are NOT met — AF, spontaneous breathing, low-VT ventilation, open chest, RV failure — SVV/PPV are invalid; use a passive leg raise (PLR) with a real-time CO instead.[7]

[7] [10]

Uncalibrated pulse contour analysis (FloTrac / Vigileo)

Uses only an arterial line (no central venous line, no calibration injectate). An algorithm estimates the CO from the arterial pulse contour and the patient demographics (age, sex, weight, height) — the so-called "demographic-based vascular compliance". The Vigileo monitor + FloTrac sensor is the prototype.[1]

• Less accurate than calibrated methods, especially when the vascular tone changes (vasopressors, vasodilation — the algorithm assumes a standard vascular compliance).
• Useful for trends rather than absolute values; the algorithm updates every 20 s to 1 min.
• The easiest to set up (just an arterial line and a monitor) — no central venous line, no calibration, no femoral line.
• Provides SVV/PPV for fluid responsiveness (subject to the same conditions as PiCCO). [1]

Cross-check the absolute CO against echo (LVOT VTI) if the number drives a big decision (inotrope titration, MCS weaning), especially after major vascular-tone change.[1]

Lithium dilution (LiDCO) — the calibrated radial-line alternative

LiDCO calibrates a pulse-contour algorithm using a lithium dilution curve rather than thermodilution. A small bolus of lithium chloride (0.002–0.003 mmol/kg) is injected via a central or peripheral venous line; the lithium concentration–time curve is detected by a lithium-selective electrode placed in a peripheral arterial line (radial is fine), and the area under the curve gives the cardiac output. That CO calibrates the PulseCO pulse-contour algorithm, which then gives continuous CO, SVV and PPV from the arterial trace.[1]

LiDCO suits the patient who needs calibrated continuous CO and SVV but for whom a femoral line is undesirable. Like all pulse-contour systems, it loses accuracy when vascular tone swings.[1]

Esophageal Doppler — continuous CO from the descending aorta

An esophageal Doppler probe (CardioQ, Hemosonic) is passed into the esophagus (depth ~35–40 cm from the teeth, behind the descending thoracic aorta) and uses continuous-wave Doppler to measure blood flow velocity in the descending aorta. The velocity–time integral × the aortic cross-sectional area (estimated from nomograms or measured) gives stroke volume and hence continuous CO. It also gives flow time corrected (FTc) — a preload marker (low FTc <330 ms suggests hypovolaemia).[1]

Esophageal Doppler is most established in perioperative goal-directed therapy for major surgery, where FTc-guided fluid boluses reduce postoperative complications.[9]

Echocardiography as a non-invasive alternative

Echocardiography is the most versatile monitoring tool in the ICU: non-invasive, rapid, repeatable, and able to answer the central haemodynamic questions at the bedside — is the heart failing, is it empty, is there obstruction (tamponade/PE), and what is the cardiac output? It bridges the basic and advanced tiers and is the leading non-invasive alternative to invasive CO monitoring.[1][10]

Basic (focused) vs advanced (quantitative) echocardiography

[1]

Measuring cardiac output — the LVOT VTI method

SV = LVOT area × LVOT VTI, where LVOT area = π × (d/2)² from the LVOT diameter d measured in the long axis (5-chamber view), and LVOT VTI is the velocity–time integral from pulsed-wave Doppler in the 5-chamber/apical long-axis view. CO = SV × HR. Repeating the VTI before and after an intervention (PLR, fluid bolus, inotrope) tracks the response — a ≥10–15% rise in VTI after PLR = fluid responsive. This is the most practical echo-based fluid-responsiveness test and needs only basic Doppler skills.[10]

When to escalate to transoesophageal echo (TOE)

• Poor transthoracic windows (obesity, surgical emphysema, dressings, pacing wires).
• Suspected endocarditis with prosthetic valves.
• Suspected aortic dissection, intra-cardiac thrombus, or source of embolus.
• Cardiac arrest (TOE for reversible causes and to guide CPR/ECMO cannulation). [1]

Limitations of echocardiography as a monitor

It is intermittent (snapshots, not continuous), operator-dependent, qualitative unless advanced-certified, and limited by image quality. It complements — but does not replace — continuous invasive monitoring in the unstable patient. The strength is the first look in any unexplained shock: failing, empty, or obstructed.[1]

The key measurements and what they tell you

The clinical principle: the choice of device depends on the question. Need the filling pressure (is the LV overloaded)? — the PAC PAWP. Need the volume status (is the patient dry or wet)? — the PiCCO GEDV. Need the fluid responsiveness (will the patient respond to a bolus)? — the SVV/PPV (from PiCCO or FloTrac, if the conditions are met). Need the oxygen balance (is the DO2 adequate)? — the SvO2 (PAC).[1][1]

Choosing the monitor — a decision framework

[7] [10] [5] [6] [9]

Device-to-device comparison

[1] [1] [10]

Landmark trials in advanced haemodynamic monitoring

[1] [1]

Exam practice

[1]

Sample Viva 1 — The PAC pressure roadmap

Examiner: "Describe the pressure waveforms you expect to see as you float a pulmonary artery catheter from the right internal jugular vein." [1]

Expected response: "From the RIJ, the catheter first enters the right atrium — a low-pressure trace (2–8 mmHg mean) with the characteristic a, c, and v waves and x and y descents. As it crosses the tricuspid valve into the right ventricle, the systolic pressure rises sharply to ~15–30 mmHg while the diastolic stays low at 2–8 mmHg. Crossing the pulmonary valve into the pulmonary artery is signalled by the diastolic pressure stepping up to ~5–15 mmHg while the systolic is unchanged (the dicrotic notch of pulmonic valve closure appears). Finally, when the balloon wedges in a branch PA, the trace falls to a venous/atrial waveform at 4–12 mmHg mean — the pulmonary artery wedge pressure, which reflects left atrial pressure. I read all pressures at end-expiration and, for the wedge, at end-diastole." [1]

Follow-up: "How do you confirm you are truly wedged, and what is the risk of over-wedging?" [1]

Response: "The wedge is confirmed by the abrupt fall to a venous-type trace on balloon inflation, a wedge pressure lower than the PA diastolic, and (when deflated) return of the PA trace with an blood sample showing a fully oxygenated (pulmonary venous) saturation. The risk of over-wedging is pulmonary artery infarction distal to the wedged segment and, more dangerously, pulmonary artery rupture — presenting as catastrophic haemoptysis. I inflate slowly, stop the moment the wedge trace appears, never leave the balloon inflated, and never advance against resistance." [1]

Sample Vica 2 — Pulmonary hypertension crisis

Examiner: "A patient with severe systemic-sclerosis-associated pulmonary arterial hypertension is admitted in pulmonary hypertensive crisis — hypotensive, hypoxic, and oliguric. What haemodynamic monitoring will you use and why?" [1]

Expected response: "This is one of the legitimate indications for a pulmonary artery catheter. CTD-associated PAH is pre-capillary pulmonary hypertension with a vulnerable, pressure-overloaded right ventricle; in crisis the RV fails, CO falls, and systemic hypotension compromises coronary perfusion of the RV. I need to know the mPAP, PA diastolic and wedge (to confirm pre-capillary PAH and exclude a post-capillary contribution), the PVR, the CO and the mixed SvO2 — and to titrate pulmonary vasodilators (inhaled nitric oxide, prostacyclin) and inotropes/vasopressors against these numbers. The PAC also lets me monitor RV failure and the response to therapy. An echocardiogram (RV size, septal shift, TAPSE, RVSP from the TR jet) complements but does not replace the PAC for pressure measurement. I would also place an arterial line (continuous BP) and ensure pacing is available, as right-heart catheterisation can provoke arrhythmia." [1]

Follow-up: "What are the specific risks of a PAC in this patient?" [1]

Response: "Pulmonary artery rupture is the feared complication and this patient has several risk factors: pulmonary hypertension itself, likely anticoagulation, and a stiff, hypertensive PA tree. I would avoid distal wedging, inflate the balloon slowly and stop as soon as the wedge trace appears, never leave the balloon inflated, and not advance against resistance. Arrhythmia and transient right bundle branch block are also risks — if she had a pre-existing left bundle branch block I would ensure pacing is available before insertion, because the catheter can cause complete heart block." [1]

Clinical pearls

Red flags

References

1. [1]De Backer D, Vincent JL. The pulmonary artery catheter: is it still alive? Curr Opin Crit Care, 2018.PMID 29608456
2. [2]Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators JAMA, 1996.PMID 8782638
3. [3]Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial JAMA, 2005.PMID 16204662
4. [4]Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial Lancet, 2005.PMID 16084255
5. [5]Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury N Engl J Med, 2006.PMID 16714768
6. [6]Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense Crit Care Med, 2013.PMID 23774337
7. [7]Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine Intensive Care Med, 2014.PMID 25392034
8. [8]Sakka SG, Klein M, Reinhart K, Meier-Hellmann A. Prognostic value of extravascular lung water in critically ill patients Chest, 2002.PMID 12475851
9. [9]Pearse RM, Harrison DA, MacDonald N, et al. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review JAMA, 2014.PMID 24842135
10. [10]De Backer D, Aissaoui N, Cecconi M, et al. Effective hemodynamic monitoring Crit Care, 2022.PMID 36171594